The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis

被引:61
作者
Bin, LH
Li, XY
Xu, LG
Shu, HB
机构
[1] Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, CU Canc Ctr, Denver, CO 80206 USA
[3] Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China
关键词
TNF-related apoptosis-inducing ligand; Casper-S/c-FLIPs; apoptosis; functional cloning; inhibitor;
D O I
10.1016/S0014-5793(01)03222-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) is a member of the tumor necrosis factor family that selectively induces apoptosis of cancer cells. However, some cancer cells or subpopulations within cancer cell lines are resistant to TRAIL-induced apoptosis. We developed a retroviral cDNA library-based functional cloning approach to unambiguously identify putative inhibitory genes of TRAIL-induced apoptosis. This effort identified the short splice form of Casper/c-FLIP, Casper-S/c-FLIPs, as a major cellular protein that confers resistance to TRAIL-induced apoptosis. Furthermore, we found that Casper deficient embryonic fibroblasts (EFs) were highly sensitive while their wild-type counterparts were completely resistant to TRAIL-induced apoptosis. Retroviral-mediated transduction of Casper-S/c-FLIPs into Casper (-/-) EFs restored resistance to TRAIL. These data suggest that Casper-S/c-FLIPs is a major cellular inhibitor of TRAIL-induced apoptosis. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 22 条
  • [1] Abe K, 2000, ANN NY ACAD SCI, V926, P52
  • [2] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [3] Control of apoptosis by Rel/NF-κB transcription factors
    Barkett, M
    Gilmore, TD
    [J]. ONCOGENE, 1999, 18 (49) : 6910 - 6924
  • [4] Rel/NF-κB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1
    Bernard, D
    Quatannens, B
    Vandenbunder, B
    Abbadie, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 27322 - 27328
  • [5] Griffith TS, 1998, J IMMUNOL, V161, P2833
  • [6] TRAIL: a molecule with multiple receptors and control mechanisms
    Griffith, TS
    Lynch, DH
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 559 - 563
  • [7] Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways
    Hu, WH
    Johnson, H
    Shu, HB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30603 - 30610
  • [8] Inhibition of death receptor signals by cellular FLIP
    Irmler, M
    Thome, M
    Hahne, M
    Schneider, P
    Hofmann, B
    Steiner, V
    Bodmer, JL
    Schroter, M
    Burns, K
    Mattmann, C
    Rimoldi, D
    French, LE
    Tschopp, J
    [J]. NATURE, 1997, 388 (6638) : 190 - 195
  • [9] TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity
    Kirchhoff, S
    Müller, WW
    Krueger, A
    Schmitz, I
    Krammer, PH
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (11) : 6293 - 6300
  • [10] Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex
    Krueger, A
    Schmitz, I
    Baumann, S
    Krammer, PH
    Kirchhoff, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) : 20633 - 20640